Combination of lymphoproliferative diseases and pregnancy-Reference-Cited by-同舟云学术

Combination of lymphoproliferative diseases and pregnancy

Published:2023-12-07 Issue:4 Volume:18 Page:64-69
ISSN:2413-4023
Container-title:Oncohematology
language:
Short-container-title:Onkogematologiâ

Author:

Chernyshova A. L.¹^ORCID,Chernyakov A. A.¹^ORCID,Popova N. O.¹^ORCID,Kravchuk T. L.¹^ORCID,Trushchuk Yu. M.¹,Dil’ O. S.¹^ORCID,Krasil’nikov S. E.²^ORCID,Antipov V. A.²^ORCID,Shumeykina A. O.²

Affiliation:

1. Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences

2. E.N. Meshalkin National Medical Research Center, Ministry of Health of Russia

Abstract

The article presents an analysis of the current state of the problem of the combination of lymphoproliferative diseases associated with pregnancy. Analysis of literature sources has shown that despite the seemingly obvious unfavorable relationship between pregnancy and lymphoproliferative diseases, most studies demonstrate a favorable prognosis regarding the prognosis and outcome of this oncological pathology in combination with pregnancy. The Research Institute of Oncology of the Tomsk SRI has sufficient experience in the treatment of this pathology, including on the background of pregnancy. We have presented two clinical cases in which successful treatment of lymphoproliferative processes in pregnant women has been demonstrated.

Publisher

Publishing House ABV Press

Subject

Oncology,Hematology

Reference21 articles.

1. State of oncological care in Russia in 2021. Eds.: А.D. Kaprin, V.V. Starinskiy, A.O. Shachzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2022. 239 p. (In Russ.).

2. Zhang J., Shynlova O., Sabra S. et al. Immunophenotyping and activation status of maternal peripheral blood leukocytes during pregnancy and labour, both term and preterm. J Cell Mol Med 2017;21(10):2386–402. DOI: 10.1111/jcmm.13160

3. Abu-Raya B., Michalski C., Sadarangani M., Lavoie P.M. Maternal immunological adaptation during normal pregnancy. Front Immunol 2020;11:575197. DOI: 10.3389/fimmu.2020.575197

4. Mehta A.K., Kadel S., Townsend M.G. et al. Macrophage biology and mechanisms of immune suppression in breast cancer. Front Immunol 2021;12:643771. DOI: 10.3389/fimmu.2021.643771

5. Jungles K.M., Holcomb E.A., Pearson A..N et al. Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer. Front Oncol 2022;12:1022542. DOI: 10.3389/fonc.2022.1022542